Pharma Finance

Finance and Investment in the Pharma Market

In this section you will find information products covering Finance and Investment within the biopharmaceutical market, including latest technologies, company profiles, biopharmaceuticals, market data and information covering Europe, the UK, North America and Asia.

 


Stay up-to-date with new products added to this category »
Title Publication Date Price
Biobetters
Major Players and Market Prospects (2nd edition)
September 2011 £355
REMS: A Standardized Approach to Risk Management September 2010 £295
Pricing & Reimbursement in Emerging Markets
Analysis of pricing mechanisms and the influence of public and private sector health insurance provision
August 2010 £2425
The Funding Landscape for Small Biopharma Ventures, 2010-2015
Trends, strategies and priorities
July 2010 £2425
Pharma's Leaking 4.4% of Revenue Annually December 2009 £950
Business Strategy: Revenue Leakage — Pharma's $11 Billion Problem December 2009 £2845
Life Sciences Funding
2008
December 2009 £4110
Healthcare Stakeholders in Latin America
Secrets of Engagement
December 2009 £235
Business Trends: Pharmaceuticals Technology Understanding Your Life Sciences Customer, 2009 (Customer Focus)
Technology
November 2009 £2145
Pharma Corporate Venture Capital (CVC): key players, new conditions and big opportunities September 2009 £295
Investment Patterns in the Healthcare Industry- An Analysis September 2009 £3795
Business Strategy: Western European, Healthcare Sector Spending 2008–2012 Special Update May 2009 £6325
Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape December 2008 £2405
Financial Markets Research: Spectrum Pharmaceuticals\' Oral Satraplatin
Oral therapy to take share in second-line hormone-refractory prostate cancer market
September 2006 £1390
Financial Markets Research: Palatin Technologies\' Bremelanotide
Competition and regulatory risk cloud potential
September 2006 £1390
Financial Markets Research: Sirona Dental Systems
Likely struggle for impressive annual growth despite strong reputation and technology
September 2006 £1390
Financial Markets Research: ASCO Review Part IICO 2006 Annual Meeting
A summary of highlights presented at the ASCO 2006 Annual Meeting
August 2006 £1390
Financial Markets Research: Renovis, Inc.\'s NXY-059
Safety profile and unmet need could drive approval
August 2006 £1390
Financial Markets Research: Santarus, Inc.\'s Zegerid
Fast-acting formulation gaining momentum in GERD
August 2006 £1390
Financial Markets Research: Endo Pharmaceuticals’ Lidoderm
Physician survey indicates increased use likely to fuel above-consensus sales growth
August 2006 £1390
Financial Markets Research: ASCO Review Part II
A summary of highlights presented at the ASCO 2006 Annual Meeting
August 2006 £1390
UK Pharmaceutical Executive Pay
Insight into Director Remuneration
January 2005 £25
UK Pharmaceutical Executive Pay - Executive Summary only
Insight into Director Remuneration
January 2005 £0
Guide to Venture Capital in European Biopharma September 2004 £410

Receive latest news

Keep me up-to-date with exciting new reports and offers
(maximum 1 email a week)


Captcha

NOTE: We will never sell, rent or loan your e-mail address to any other organisation. Remember you can unsubscribe at any time.

Follow us on twitter